
What We’re Reading: AHIP President to Step Down; House Panel Advances PBM Bills; Default Could Stop FDA Reviews
AHIP president and CEO Matthew Eyles will step down later this year; the House Energy and Commerce Committee moved a series of health care measures concerning pharmacy benefit managers (PBMs); US debt default could stop FDA drug and device reviews, said FDA chief.
AHIP President and CEO to Step Down
President and CEO of America’s Health Insurance Plans (AHIP) Matthew Eyles has decided to step down from the group in October after almost 5 years at the helm,
House Panel Furthers Transparency and PBM Bills
The House Energy and Commerce Committee moved ahead a series of health care measures to elevate price transparency and reconstruct regulation of pharmacy benefit managers (PBMs) in a predominantly bipartisan markup Wednesday,
US Debt Default Could Stop Drug, Device Approvals
FDA approvals of emerging drugs and devices will stop if the debt ceiling negotiations fail and the US defaults on its debt, said Commissioner Robert Califf,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.